Laura Sutcliffe
Stock Analyst at Citi
(2.54)
# 3,020
Out of 4,792 analysts
492
Total ratings
50.3%
Success rate
1.3%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintained: Hold | $235 → $240 | $219.95 | +9.12% | 15 | Sep 10, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $39.50 | $41.31 | -4.38% | 17 | Sep 10, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $140.00 | $137.58 | +1.76% | 18 | Sep 10, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $160.00 | $169.50 | -5.60% | 42 | Sep 10, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $240.00 → $225.00 | $166.87 | +34.84% | 8 | Sep 10, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $49.00 | $53.70 | -8.75% | 18 | Sep 10, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | $33.00 | $30.30 | +8.91% | 23 | Sep 10, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $22.00 | $19.37 | +13.58% | 17 | Sep 10, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $31.00 | $16.76 | +84.96% | 38 | Sep 10, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $27.74 | $20.05 | +38.34% | 7 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $43.95 | - | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €40.00 → €34.00 | €23.86 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 86.00 → CHF 84.00 | CHF 113.04 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | €74.03 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.68 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 1,850p → 1,820p | 1,793p | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $33.04 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $137.48 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $1,002.31 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $87 → $90 | $27.43 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €108.00 | €132.23 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $42.85 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.63 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $303 → $300 | $44.56 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,124.21 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $64.41 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $145.65 | n/a | 14 | Oct 18, 2017 |
ResMed
Sep 10, 2026
Maintained: Hold
Price Target: $235 → $240
Current: $219.95
Upside: +9.12%
Ansell Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $39.50
Current: $41.31
Upside: -4.38%
Cochlear Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $140.00
Current: $137.58
Upside: +1.76%
CSL Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $160.00
Current: $169.50
Upside: -5.60%
Pro Medicus Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $240.00 → $225.00
Current: $166.87
Upside: +34.84%
Ramsay Health Care Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $49.00
Current: $53.70
Upside: -8.75%
ResMed Inc.
Sep 10, 2026
Reiterated: Hold
Price Target: $33.00
Current: $30.30
Upside: +8.91%
Sonic Healthcare Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $22.00
Current: $19.37
Upside: +13.58%
Telix Pharmaceuticals Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $31.00
Current: $16.76
Upside: +84.96%
EBOS Group Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $27.74
Current: $20.05
Upside: +38.34%
Sep 10, 2026
Upgraded: Buy
Price Target: n/a
Current: $43.95
Upside: -
May 7, 2024
Reiterated: Hold
Price Target: €40.00 → €34.00
Current: €23.86
Upside: n/a
Dec 14, 2022
Reiterated: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: CHF 113.04
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: €74.03
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $14.68
Upside: n/a
Aug 8, 2022
Reiterated: Hold
Price Target: 1,850p → 1,820p
Current: 1,793p
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $33.04
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $137.48
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $1,002.31
Upside: n/a
Apr 12, 2021
Reiterated: Hold
Price Target: $87 → $90
Current: $27.43
Upside: n/a
Feb 28, 2020
Reiterated: Hold
Price Target: €108.00
Current: €132.23
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $42.85
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $48.63
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $303 → $300
Current: $44.56
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,124.21
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $64.41
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $145.65
Upside: n/a